Peer-Reviewed Publication
Transl Stroke Res2026;17(2)February 25, 2026Journal Article
Cerebrolysin after Endovascular Thrombectomy in Stroke: 12‑Month Functional Outcomes in a Propensity‑Matched Cohort.
Jacek Staszewski1,2, Aleksander Dębiec3, Katarzyna Gniadek-Olejniczak4, Adam Stępień3, Renata Piusinska-Macoch3, Stefan Strilciuc5, David Balo6, George Harston6,7, Krzysztof Brzozowski8, Piotr Zięcina8,9, Jerzy Narloch8, Marek Wierzbicki8, Piotr Piasecki8
1Clinic of Neurology, Military Institute of Medicine, Szaserow 128, Warsaw, 04-141, Poland. jstaszewski@wim.mil.pl.
2Faculty of Medicine, Warsaw University, Warsaw, Poland. jstaszewski@wim.mil.pl.
3Clinic of Neurology, Military Institute of Medicine, Szaserow 128, Warsaw, 04-141, Poland.
4Neurorehabilitation Clinic, Military Institute of Medicine, Warsaw, Poland.
5Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
6Brainomix Ltd., and Oxford University Hospitals NHSFT, Oxford, United Kingdom.
7Oxford University Hospitals NHSFT, Oxford, United Kingdom.
8Department of Radiology, Military Institute of Medicine, Warsaw, Poland.
9Faculty of Medicine, Warsaw University, Warsaw, Poland.
Abstract
Background Long-term outcomes after endovascular thrombectomy (EVT) and the role of adjunctive neuroprotection to achieve post-stroke independence remain incompletely characterized. In this hypothesis-generating target-trial emulation, we assessed 12-month functional outcomes in a prespecified extension of a propensity score-matched cohort of rigorously selected EVT patients treated with adjunctiv…
Create a free account to keep reading
Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.
Want unlimited research access? See Pro plans